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AbstrAct
Interleukin (IL)-21 triggers inflammatory signals that contribute to the growth 
of neoplastic cells in mouse models of colitis-associated colorectal cancer (CRC). 
Because most CRCs are sporadic and arise in the absence of overt inflammation we 
have investigated the role of IL-21 in these tumors in mouse and man. IL-21 was 
highly expressed in human sporadic CRC and produced mostly by IFN-γ-expressing 
T-bet/RORγt double-positive CD3+CD8- cells. Stimulation of human CRC cell lines with 
IL-21 did not directly activate the oncogenic transcription factors STAT3 and NF-kB 
and did not affect CRC cell proliferation and survival. In contrast, IL-21 modulated the 
production of protumorigenic factors by human tumor infiltrating T cells. IL-21 was 
upregulated in the neoplastic areas, as compared with non-tumor mucosa, of Apcmin/+ 
mice, and genetic ablation of IL-21 in such mice resulted in a marked decrease of 
both tumor incidence and size. IL-21 deficiency was associated with reduced STAT3/
NF-kB activation in both immune cells and neoplastic cells, diminished synthesis of 
protumorigenic cytokines (that is, IL-17A, IL-22, TNF-α and IL-6), downregulation 
of COX-2/PGE2 pathway and decreased angiogenesis in the lesions of Apcmin/+ mice. 
Altogether, data suggest that IL-21 promotes a protumorigenic inflammatory circuit 
that ultimately sustains the development of sporadic CRC.
INtrODUctION
Accumulation of mutations in various oncogenes 
and tumor suppressor genes drives the development of 
sporadic CRC [1], but at the same time progression of this 
neoplasia is tightly controlled by complex interactions 
between cancer cells and immune cells in the tumor 
microenvironment, with the latter modulating both 
pro- and anti-tumorigenic pathways [2]. Although these 
phenomena have been widely documented in CRC arising 
in patients with inflammatory bowel disease and in mouse 
models of chemically induced colitis-associated CRC [3-
9], recent studies have clearly shown that an immune/
inflammatory infiltrate is also present in sporadic CRC, 
and immune cell-derived cytokines sustain CRC cell 
growth and spread [10]. It is however possible that distinct 
immune mechanisms contribute to the pathogenesis of 
colitis-associated CRC in mouse and man compared to 
sporadic CRC.
The pleiotropic cytokine interleukin (IL)-21 has 
potent anti-tumor effects due to its ability to expand the 
pool of cytotoxic CD8+ T cells, NK cells and NKT cells 
[11] and beneficial IL-21-mediated anti-tumor responses 
have been documented in mice implanted with syngeneic 
tumor lines (including CRC cell lines) [12] as well as 
in patients with advanced solid tumors [13, 14]. On the 
other hand, IL-21 also drives Th17 immune responses 
[15, 16], which promote colon carcinogenesis in mice 
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and negatively influence the prognosis of patients with 
sporadic CRC [10, 17, 18]. Recent studies from our 
laboratory have shown that IL-21 is highly expressed in 
the mucosa of patients with ulcerative colitis complicated 
by CRC [9], and also plays a key role in sustaining the 
growth of cancer cells in mice with colitis-associated 
CRC [9]. Therefore, there is the possibility that IL-21 
could have opposing functions on the growth of CRCs, 
depending on the neoplastic triggers and local immune 
activation. Since our studies have also shown high IL-21 
production in the tumor areas of patients with sporadic 
CRC [9], we hypothesized that this cytokine can sustain 
the growth of sporadic CRC.
rEsULts
IFN-γ-expressing T-bet/RORγt double-positive 
CD3+CD8- cells are a major source of IL-21 in 
human sporadic CRC 
IL-21 was significantly increased in CRC samples 
as compared to non-tumor mucosa (Figure 1A). To assess 
the cellular source of IL-21 in human sporadic CRC, we 
isolated tumor infiltrating leukocytes (TILs) from patients 
who underwent surgical resection. Flow cytometry 
analysis revealed that IL-21 was mostly produced 
by CD3+CD8- T cells (Figure 1B) and minimally 
expressed by CD3+CD8+ T cells and natural killer (NK) 
T cells (CD3+CD56+ cells) (2.54±0.4 and 0.96±0.28 
respectively); no IL-21 staining was seen in NK cells 
(CD3-CD56+ cells), macrophages (CD68+ cells) and B 
cells (CD19+ cells) thus ruling out such cells as sources 
of IL-21 in human CRC (Figure 1B). Next, we evaluated 
whether IL-21 was co-expressed with Th1/Th17 signature 
cytokines (that is, IFN-γ and IL-17A respectively) 
within CD3+CD8- and CD3+CD8+ populations. Nearly 
5% of CD3+CD8- cells produced IL-21 either alone or 
in combination with IFN-γ (5.15±0.66 and 4.45±0.67 
respectively), whereas less then 2% (1.65±0.46) of such 
cells co-expressed IL-21 and IL-17A (Suppl. Figure 1A 
and B). Most of the CD3+CD8+ cells synthesized IFN-γ 
(77.1±8.25), whereas less than 3% of such cells expressed 
either IL-21 alone (0.3±0.11) or in combination with 
IFN-γ or IL-17A (2.8±1.17 and 0.42±0.14 respectively) 
(Suppl. Figure 1C and D).
The majority of IL-21-producing CD3+CD8- cells 
were T-bet/receptor-related orphan receptor gamma t 
(RORγt) double-positive and, to a lesser extent, T-bet-
RORγt+ (Figure 1C). Notably, co-expression of the 
regulatory T cell-associated transcription factor Forkhead 
box P3 (FoxP3) in T-bet/RORγt double-positive and T-bet-
RORγt+ CD3+CD8-cells associated with IL-17A but not 
IL-21 production (Figure 1C and Suppl. Figure 2). Nearly 
50% of IL-21-producing T-bet/RORγt double-positive 
CD3+CD8- cells co-expressed IFN-γ alone, whereas less 
than 15% of such cells co-expressed either IL-17A alone 
or IL-17A and IFN-γ (Figure 1D). One fifth of IL-21-
producing T-bet-RORγt+ CD3+CD8- cells co-expressed 
IL-17A alone, whereas less than 3% of such cells co-
expressed either IFN-γ alone or IL-17A and IFN-γ (Figure 
1D).
These findings indicate that IL-21 is preferentially 
made by IFN-γ-expressing T-bet/RORγt double-positive 
CD3+CD8- cells in human sporadic CRC.
IL-21 does not directly affect STAT3/NF-kB 
activation, proliferation and survival in human 
CRC cells
The transcription factors STAT3 and NF-kB 
are key mediators in the interplay between immune/
inflammatory cells and malignant cells and their activation 
stimulates proliferation and survival of CRC cells [19]. 
IL-21 receptor was expressed by DLD-1 and HT-29, two 
human CRC cell lines (Suppl. Figure 3A). However, no 
significant change in STAT3 and NF-kB activation was 
seen in DLD-1 and HT-29 cells following stimulation 
with increasing doses of IL-21 for different time points 
(Suppl. Figure 3B and not shown). Similarly, IL-21 did not 
change the rate of proliferation and the survival of DLD-1 
and HT-29 cells, whereas a robust proliferation of both 
CRC cell lines was seen in the presence of TIL-derived 
supernatants (Suppl. Figure 3C and D). IL-21 activated 
STAT3 in human normal lamina propria mononuclear cells 
(LPMCs) isolated from the macroscopically unaffected 
colonic mucosa of CRC patients, thus indicating that the 
cytokine was biologically active (Suppl. Figure 4).
To determine whether IL-21 controls pro- and 
anti-tumorigenic signals in immune cells infiltrating the 
tumor, TILs were isolated from sporadic CRC of four 
patients, activated with anti-CD3/CD28 in the presence of 
either a control IgG or IL-21 neutralizing antibody and 
examined by flow cytometry. Blockade of IL-21 reduced 
the fraction of IL-17A- and IL-22-producing CD3+CD8- 
cells, whereas no significant changes where observed in 
the fraction of IL-6- and IFN-γ-producing CD3+CD8- 
cells (Figure 1E).
IL-21-knockout-Apcmin/+ mice are resistant to 
colon tumorigenesis
To further evaluate the role of IL-21 in sporadic CRC 
in vivo we used Apcmin/+ mice. IL-21 was overexpressed 
in the colonic lesions of Apcmin/+ mice treated with AOM 
and killed on day 56 (Figure 2A) as compared to the non-
tumor areas (Figure 2B). Both Apcmin/+ (control) and IL-
21-knockout (IL-21 KO)-Apcmin/+ mice were injected with 
AOM and monitored for tumor formation. Four Apcmin/+ 
mice had to be killed before the end of the scheduled 
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Figure 1: Characterization of IL-21-producing cells in human sporadic colorectal cancer (CRC). A. Total proteins 
extracted from both tumor (T) and non-tumor (NT) areas of two patients with sporadic CRC were evaluated for IL-21 expression by western 
blotting. β-actin was used as loading control. The figure is representative of five separate experiments. Right inset. Quantitative analysis 
of IL-21/β-actin protein ratio. Values are expressed in arbitrary units (a.u.) and indicate the mean ± SEM of all experiments (n=10). B. IL-
21 is preferentially made by CD3+CD8- cells in tumor infiltrating leukocytes (TILs). Left panel. Representative histograms showing the 
percentage of CD45+IL-21+ cells in TILs. The example is representative of five experiments in which cells isolated from five patients with 
sporadic CRC were analyzed. Numbers above lines indicate the percentages of CD45+IL-21+ cells. Staining of cells with PE-conjugated 
control isotype IgG is also shown. Central panels. Representative dot-plots showing the fraction of IL-21+ cells in TILs. CD45+IL-21+ and 
CD45+IL-21- cells were gated and then analyzed for the indicated markers. The numbers indicate the percentage of cells in the designated 
quadrants. The example is representative of five experiments in which cells isolated from five patients with sporadic CRC were analyzed. 
Right panel. Representative histograms showing the fraction of IL-21+ cells in TILs. CD45+IL-21+ cells were gated and then analyzed for 
the indicated markers. Data are expressed as mean ± SEM of five experiments in which cells isolated from five patients with sporadic CRC 
were analyzed. C-D. IL-21 is preferentially made by IFN-γ-expressing T-bet/RORγt double-positive CD3+CD8- cells in human sporadic 
CRC. C. Representative histograms showing the percentages of IL-21-producing CD3+CD8- cells expressing the indicated transcription 
factors. Data are expressed as mean ± SEM of five experiments in which TILs isolated from five patients with sporadic CRC were analyzed. 
D. IL-17A and IFN-γ expression was analyzed in T-bet-RORγt+ and T-bet/RORγt double-positive IL-21-producing CD3+CD8- cells by 
flow cytometry. The numbers indicate the percentage of cells in the designated quadrants. Right panels. Percentages of T-bet-RORγt+ and 
T-bet/RORγt double-positive IL-21-producing CD3+CD8- cells co-expressing IL-17A and/or IFN-γ. Data are expressed as mean ± SEM 
of five experiments in which TILs isolated from five patients with sporadic CRC were analyzed. E. TILs isolated from four patients with 
sporadic CRC were cultured either with a control IgG or anti-IL-21 antibody (both used at 10 µg/ml) for 48 h. Each point represents the 
percentage of IL-17A-, IL-22-, IL-6- and IFN-γ-producing CD45+CD3+CD8- cells, assessed by flow cytometry, in TILs isolated from a 
single patient.
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Figure 2: IL-21 deficiency significantly reduces colon tumorigenesis in Apcmin/+ mice. A. Experimental protocol used to assess 
the effect of IL-21 ablation on colon tumorigenesis in Apcmin/+ mice. B. Representative western blotting showing IL-21 expression in colon 
tissues taken from Apcmin/+ mice killed on day 56. β-actin was used as loading control. One of five representative experiments is shown. 
NT, non-tumor area, T, tumor area. Right inset. Quantitative analysis of IL-21/β-actin protein ratio in total extracts of T and NT colon 
tissues taken from Apcmin/+ mice killed on day 56 as measured by densitometry scanning of western blots. Values are expressed in arbitrary 
units (a.u.) and indicate the mean ± SEM of all experiments (n=5). C. Representative endoscopic pictures of colon tumors developed in 
Apcmin/+ mice and IL-21 KO-Apcmin/+ mice. Graphs show the number of lesions and the endoscopic scoring of tumors. Data indicate mean 
± SEM of four independent experiments in which at least four mice per group were considered. D. Representative images showing PCNA 
immunostaining in colon sections taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. The scale bars are 20µm. One of 
four representative experiments in which similar results were obtained is shown.
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treatment, because of intestinal occlusion caused by large 
colonic tumors, whereas all the IL-21-KO-Apcmin/+ mice 
survived until the end of the study.
Endoscopy on day 54 showed that control mice 
developed multiple large tumors whereas the number and 
size of tumors were reduced in the colon of IL-21 KO-
Apcmin/+ mice (Figure 2C). These results were confirmed 
by direct assessment of tumors in mice killed on day 56 
(unpublished data). Proliferating cell nuclear antigen 
(PCNA) staining confirmed that lack of IL-21 reduces the 
rate of proliferation in transformed epithelial cells (Figure 
2D). By contrast, there was no significant change in PCNA 
staining in the normal colonic mucosa of control and IL-
21-KO-Apcmin/+ mice (Figure 2D).
To investigate whether IL-21 deficiency affects 
the fraction and/or the function of immune cell subsets 
involved in anti-tumor immunity, LPMCs and TILs 
isolated from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice 
were analyzed for CD8 and CD49b by flow cytometry. 
IL-21 deficiency associated with no change in the numbers 
of cytotoxic T cells and NK cells in both LPMCs and TILs 
(Figure 3A). However, lack of IL-21 significantly reduced 
the fraction of perforin- and/or granzyme B-producing NK 
and CD8 T cells in TILs (Figure 3B and C).
Because CD4+ T cells play a pivotal role in the 
growth of sporadic CRC, we next determined whether 
the diminished tumor incidence and severity in IL-21-
deficient mice was associated with reduced infiltration 
and/or function of colonic CD4+ cells. Although lack 
of IL-21 did not alter the number of CD4-expressing 
LPMCs and TILs (Figure 4A), TILs isolated from IL-
21-deficient Apcmin/+ mice showed an increased fraction 
of CD4+Foxp3+ T cells (Figure 4B) and a diminished 
percentage of IL-17A-positive and IFN-γ/IL-17A double-
positive CD4 T cells (Figure 4C).
Reduced STAT3/NF-kB activation and reduced 
expression of IL-17A, IL-22, TNF-α and IL-6 in 
the tumors of IL-21 KO-Apcmin/+ mice
Hyper-activation of the transcription factors STAT3 
and NF-kB makes a major contribution to the tumorigenic 
process in the colon. To determine whether the reduced 
carcinogenesis observed in IL-21 KO-Apcmin/+ mice was 
associated with a reduced activation of STAT3 and/or 
NF-kB, we compared p-STAT3 Y705 and p-NF-kB/p65 
Ser536 expression in non-tumor and tumor tissues derived 
from colonic extracts of control and IL-21 KO-Apcmin/+ 
mice killed on day 56. Robust activation of both STAT3 
and NF-kB was seen in the neoplastic areas of control 
mice compared to those derived from IL-21 KO-Apcmin/+ 
mice, whereas p-STAT3 Y705 and p-NF-kB/p65 Ser536 
expression was barely detectable in non-tumor areas of 
both control and IL-21-deficient Apcmin/+ mice (Suppl. 
Figure 5A). Similar findings were seen when STAT3 and 
NF-kB activation was assessed by immunohistochemistry 
(Figure 5A and B), which also revealed a reduction of cells 
positive for p-STAT3 Y705 and p-NF-kB/p65 Ser536 in 
both transformed epithelial cells and tumor infiltrating 
cells in the lesions of IL-21 KO-Apcmin/+ mice (Figure 5A 
and B).
As the ability of immune/inflammatory cells to 
activate protumorigenic signals in transformed cells is 
mostly dependent on cytokines and IL-21 regulates the 
induction of multiple protumorigenic cytokines [20, 21], 
we next analyzed the cytokine profile in the colon of 
control and IL-21 KO-Apcmin/+ mice. The STAT3- or NF-
kB-activating cytokines IL-17A, IL-22, TNF-α and IL-6 
were reduced in the tumors of IL-21 KO-Apcmin/+ mice 
at both the RNA and protein level (Figure 5C and Suppl. 
Figure 5B), whereas such cytokines were barely detectable 
in non-tumor areas of both control and IL-21 KO-Apcmin/+ 
mice (Figure 5C and Suppl. Figure 5B).
Taken together, these results suggest that elevated 
levels of IL-21 in the tumors of Apcmin/+ mice support 
a tumor-promoting inflammatory microenvironment 
characterized by enhanced production of IL-17A, IL-22, 
TNF-α and IL-6 and hyper-activation of STAT3/NF-kB.
IL-21 indirectly affects proliferation and STAT3/
NF-kB activation in mouse CRC cells
To determine whether the pro-tumorigenic effect 
of IL-21 in our experimental model of CRC was due to 
a direct action of the cytokine on transformed epithelial 
cells, we used immortalized CRC cells derived from 
C57BL/6J mice (that is, MC38). IL-21 affected neither 
STAT3/NF-kB activity nor proliferation rate in MC38 
cells (Suppl. Figure 6A and B). Of note, both STAT3 and 
NF-kB were activated in MC38 cells when cultured in the 
presence of TIL SNs derived from Apcmin/+ mice but not 
from IL-21 KO-Apcmin/+ mice (Figure 6A). Consistently, 
Apcmin/+ mice-derived TIL SNs significantly increased 
MC38 cell growth compared with IL-21 KO-Apcmin/+ mice-
derived TIL SNs (Figure 6B).
IL-21 deficiency impairs COX-2/PGE2 pathway 
and angiogenesis in the tumors of Apcmin/+ mice
Since induction of COX-2 and its product PGE2 
by IL-6 and TNF-α positively influences colorectal 
tumorigenesis [22], we next examined whether IL-21 
deficiency affects the COX-2/PGE2 axis in Apcmin/+ mice. 
In both control and IL-21 KO-Apcmin/+ mice, COX-2 RNA 
and protein were increased in the tumors as compared to 
non-tumor areas (Figure 7A and B), though induction of 
COX-2 was markedly diminished in the absence of IL-21 
(Figure 7A and B). Consistently, lack of IL-21 markedly 
decreased PGE2 in the tumors of Apcmin/+ mice (Figure 
7C). Our results are in line with previous reports showing 
Oncotarget9913www.impactjournals.com/oncotarget
Figure 3: IL-21 deficiency in Apcmin/+ mice associates with a reduced fraction of perforin and/or granzyme B-producing 
CD49b- and CD8-positive cells in TILs. A. Representative dot-plots showing CD49b- and CD8-positive cells in LPMCs and TILs 
isolated from the colon of Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. Numbers indicate the percentages of cells in the 
designated quadrants. One of four representative experiments is shown. Right insets. Representative histograms showing the fraction of 
CD49b- and CD8-positive cells in LPMCs and TILs isolated from the colon of Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. 
CD45-positive cells were gated and analyzed for the indicated markers. Values are mean ± SEM of two independent experiments containing 
at least two mice per group. B-C. TILs isolated from the colon of Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56 were assessed 
for perforin- and granzyme B-expressing CD49b- (B) and CD8-positive cells (C) by flow cytometry. The numbers indicate the percentage 
of cells in the designated quadrants. Right panels. Percentages of CD49b- (B) and CD8-positive cells (C) co-expressing perforin and/or 
granzyme B. Data are expressed as mean ± SEM of two independent experiments containing at least two mice per group.
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Figure 4: IL-21 deficiency in Apcmin/+ mice associates with a functional switch of TIL-derived CD4-positive cells. A. 
Representative dot-plots showing CD4-positive cells in LPMCs and TILs isolated from the colon of Apcmin/+ mice and IL-21 KO-Apcmin/+ 
mice killed on day 56. Numbers indicate the percentages of cells in the designated quadrants. One of four representative experiments is 
shown. Right insets. Representative histograms showing the fraction of CD4-positive cells in LPMCs and TILs isolated from the colon of 
Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. CD45-positive cells were gated and analyzed for the indicated markers. Values 
are mean ± SEM of two independent experiments containing at least two mice per group. B. TILs isolated from the colon of Apcmin/+ mice 
and IL-21 KO-Apcmin/+ mice killed on day 56 were assessed for Foxp3-expressing CD4-positive cells by flow cytometry. The numbers 
indicate the percentage of cells in the designated quadrants. Graph shows the fraction of Foxp3-positive CD4 T cells in TILs isolated from 
the colon of Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. Data are expressed as mean ± SEM of two independent experiments 
containing at least two mice per group. C. TILs isolated from the colon of Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56 were 
assessed for IFN-γ- and/or IL-17A-expressing CD4-positive cells by flow cytometry. The numbers indicate the percentage of cells in the 
designated quadrants. Graph shows the fraction of IFN-γ- and/or IL-17A-expressing CD4 T cells in TILs isolated from the colon of Apcmin/+ 
mice and IL-21 KO-Apcmin/+ mice killed on day 56. Data are expressed as mean ± SEM of two independent experiments containing at least 
two mice per group.
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Figure 5: Reduced STAT3/NF-kB activation and reduced expression of IL-17A, IL-22, TNF-α and IL-6 in the tumors 
of IL-21 KO-Apcmin/+ mice. A-B. Representative images showing p-STAT3 Tyr705- (A) or p-NF-kB/p65 Ser536-positive cells (B) in 
colon sections taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. Staining with isotype control IgG is also shown. The 
scale bars are 20µm. The scale bar in the inset is 10µm. One of four representative experiments is shown. Upper left insets. Quantification 
of p-STAT3 Tyr705- (A) or p-NF-kB/p65 Ser536-positive (B) infiltrating and epithelial cells in colon sections taken from the tumor areas 
of Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. Data are presented as mean values of positive cells per high power field (hpf) 
± SEM of two independent experiments in which at least two sections per group were analyzed. NT, non-tumor area, T, tumor area. C. IL-
17A, IL-22, TNF-α and IL-6 expression was assessed by ELISA in colon tissues taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed 
on day 56. Data indicate mean ± SEM of two independent experiments in which at least four mice per group were considered.
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that deletion of the Cox-2 gene in Apcmin/+ mice results in a 
significant reduction in both the number and size of lesions 
[23, 24].
VEGF signaling has been identified as a key 
factor in the pathogenesis of sporadic colorectal tumors 
in mouse and man [25, 26], and both PGE2 and IL-17A 
are known to induce VEGF [27, 28]. Therefore, we 
investigated whether IL-21 controls VEGF and VEGF-
related angiogenic pathways in the Apcmin/+ mouse model. 
Knock-down of IL-21 reduced VEGF, p-VEGF-R2 
Tyr1175 and VEGF-R2 in the tumors of Apcmin/+ mice 
(Figure 8A and B). Consistently, a significant decrease in 
CD31-positive blood vessels, reflective of a diminished 
neo-angiogenesis, was seen in the tumors of IL-21 KO-
Apcmin/+ mice compared with control tumors (Figure 8C). 
No significant change in VEGF, p-VEGF-R2 Tyr1175 and 
VEGF-R2 expression as well as in the number of blood 
vessels was seen in the normal colon between control and 
IL-21 KO-Apcmin/+ mice (Figure 8A-C). 
DIscUssION
This study was undertaken to clarify the role of 
IL-21 in sporadic CRC. Our data confirm and expand on 
our previous work showing up-regulation of IL-21 in the 
tumor areas of patients with sporadic CRC. We here also 
show that CD3+CD8- cells infiltrating the tumor tissue are 
the major source of IL-21.
Within the tumor microenvironment, expression 
of Th1-associated molecules positively correlates with 
reduced recurrence of sporadic CRC [29], whereas 
accumulation of Th17 cells impacts negatively on the 
prognosis of patients with such a neoplasia [17, 18]. 
We investigated the phenotypic characteristic of IL-
21-producing CD3+CD8- cells by flow cytometry and 
determined whether IL-21 was co-expressed with Th1 
and/or Th17-related transcription factors (that is, T-bet 
and RORγt respectively) and cytokines (that is, IFN-γ 
and IL-17A respectively). Our data indicate that IL-21 is 
preferentially made by T-bet/RORγt double-positive Th 
cells and, to a lesser extent, by T-bet-RORγt+ Th cells. 
More than 50% of IL-21 producing Th cells co-express 
IFN-γ, thus confirming our previous studies showing 
that IFN-γ-expressing cells are a major source of IL-21 
in the colon of patients with inflammatory bowel disease 
[30]. Foxp3+RORγt+ T regulatory cells (Tregs) expand in 
CRC patients and may contribute to tumor development 
in part through the synthesis of IL-17A [31]. However, 
flow cytometry analysis of TILs showed that T-bet/RORγt 
double-positive or T-bet-RORγt+ Foxp3-expressing 
cells did not produce IL-21. This is consistent with the 
demonstration that Foxp3 binds to IL-21 gene promoter 
and suppresses IL-21 production in CD4+ cells [32].
STAT3 and NF-kB are involved in the interplay 
between immune/inflammatory and malignant cells 
and activation of such transcription factors positively 
modulates CRC cell proliferation and survival [19]. This 
notion, together with previous evidence showing that 
Figure 6: STAT3/NF-kB activation and increased proliferation are seen in mouse CRC cells cultured in the presence of 
TIL-derived supernatants (TIL SNs) obtained from Apcmin/+ mice compared to those obtained from IL-21 KO-Apcmin/+ 
mice. A. MC38 cells were cultured in the presence of either Apcmin/+ mice-derived TIL SNs or IL-21 KO-Apcmin/+ mice-derived TIL SNs or 
RPMI 1640 complete medium (control) (all used at 1:20 final dilution) for 15 min. P-STAT3 Tyr705, STAT3, p-NF-kB/p65 Ser536 and NF-
kB/p65 expression was assessed by western blotting. β-Actin was used as loading control. Shown is one of four representative experiments 
in which TIL SNs derived from four Apcmin/+ mice and four IL-21 KO-Apcmin/+ mice were used. B. MC38 cells were cultured as indicated in 
A. After 24 h, cell proliferation was assessed by BrdU assay. Data indicate mean ± SEM of four independent experiments.
Oncotarget9917www.impactjournals.com/oncotarget
gut epithelial cells express IL-21R and respond to IL-
21 [33], prompted us to investigate whether IL-21 can 
activate STAT3 and NF-kB in human CRC cells. IL-21 
failed to activate both factors in DLD-1 and HT-29 cells. 
Moreover, IL-21 did not affect proliferation and survival 
of such cells, thus arguing against a role for this cytokine 
in directly modulating malignant cell growth in colon 
carcinogenesis. In contrast, addition of a neutralizing IL-
21 antibody to cultures of TILs isolated from patients with 
sporadic CRC and maximally activated with anti-CD3/
CD28 reduced IL-17A and IL-22 production. This finding 
well fits with both in vitro and in vivo studies showing a 
key role of IL-21 in sustaining Th17 immune responses in 
the gut [21, 34].
IL-21 was upregulated in the colon lesions of 
Apcmin/+ mice as compared with the non-tumor mucosa and 
lack of IL-21 in such mice resulted in a dramatic reduction 
of both tumor incidence and size. In both LPMCs and 
TILs, IL-21 deficiency did not significantly alter the 
fraction of cytotoxic lymphocytes and NK cells and 
resulted in a diminished production of cytotoxic molecules 
by such cell populations in TILs. These data are consistent 
with previous studies showing that IL-21 is important 
for activity of CD8 and NK cells [11] and indicate that 
resistance of IL-21 KO-Apcmin/+ mice against colon 
tumorigenesis is not due to enhanced immune surveillance. 
Similarly, no change in the percentage of bulk population 
of CD4+ cells was seen in LPMCs and TILs isolated 
from control and IL-21-deficient Apcmin/+ mice. Further 
analysis of CD4+ T cell subsets in TILs showed that IL-21 
deficiency increased the fraction of Foxp3+ CD4+ T cells. 
These data are not surprising as we previously reported 
a similar effect for IL-21 in a mouse model of colitis-
associated CRC [9] and are in line with the notion that 
IL-21 suppresses the peripheral differentiation of Tregs 
[36]. In this context it is noteworthy that, although the role 
of Tregs in CRC is controversial and still under debate 
[37], regulatory T lymphocytes can induce regression 
of intestinal tumors in Apcmin/+ mice [38]. In line with 
human data, lack of IL-21 associated with a diminished 
percentage of IL-17A-producing CD4+ T cells in TILs. 
Overall the above findings indicate that IL-21 can affect 
the function of CD4+ T cells in TILs. 
The tumor tissues of IL-21 KO-Apcmin/+ mice 
exhibited reduced activation of STAT3/NF-kB and this 
was evident in both epithelial and immune cells. Mouse 
tumor epithelial cells do not express IL-21R [9], and 
stimulation of immortalized CRC cells derived from 
C57BL/6J mice with IL-21 does not affect cell growth 
and activation of STAT3/NF-kB. Altogether these data 
suggest that the reduced activation of STAT3/NF-kB 
observed in cancer cells of IL-21-deficient Apcmin/+ mice is 
Figure 7: Reduced expression of COX-2/PGE2 in the 
tumors of IL-21 KO-Apcmin/+ mice A. COX-2 was assessed 
by real-time PCR in colon tissues taken from Apcmin/+ mice and 
IL-21 KO-Apcmin/+ mice killed on day 56. Data indicate mean ± 
SEM of two independent experiments in which at least two mice 
per group were considered. NT, non-tumor area, T, tumor area. 
B. Representative western blotting showing COX-2 in colon 
tissues taken from Apcmin/+ mice and IL-21 KO Apcmin/+ mice 
killed on day 56. β-actin was used as loading control. One of four 
representative experiments is shown. Bottom inset. Quantitative 
analysis of COX-2/β-actin protein ratio in total extracts of T and 
NT colon tissues taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ 
mice killed on day 56 as measured by densitometry scanning of 
western blots. Values are expressed in arbitrary units (a.u.) and 
indicate the mean ± SEM of all experiments (n=4). C. PGE2 
levels were assessed by ELISA in colon tissues taken from 
Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. Data 
indicate mean ± SEM of two independent experiments in which 
at least three mice per group were considered.
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not due to the lack of a direct effect of IL-21 on these cells 
but probably reflects the diminished synthesis of IL-17A, 
IL-22, TNF-α and IL-6, given that these cytokines directly 
activate STAT3 (IL-22 and IL-6) or NF-kB (IL-17A and 
TNF-α) in malignant cells [19]. Since activation of STAT3 
and NF-kB in immune cells enhances the production of 
Th17-related cytokines, including IL-21 itself [21, 39, 
40], it is conceivable that IL-21 could be part of a positive 
feedback loop that amplifies tumorigenic signals in the 
colon. In support of this hypothesis, in vitro stimulation 
of mouse CRC cells with TIL SNs derived from Apcmin/+ 
mice, but not from IL-21 KO Apcmin/+ mice, promotes 
STAT3/NF-kB activation and cell proliferation.
Th17-related cytokines control induction of other 
pathways implicated in the process of colon tumorigenesis 
(for example, COX-2, VEGF). Therefore, it is not 
surprising that the reduced tumorigenesis documented 
in the absence of IL-21 was associated with reduced 
activation of COX-2/PGE2 pathway and diminished neo-
angiogenesis. These findings do not however exclude the 
possibility that the reduced expression of COX-2 and 
VEGF in IL-21 KO-Apcmin/+ mice may be linked to the 
effect of IL-21 on additional cells other than Th17. Indeed, 
it has previously been reported that IL-21 can target and 
modulate the function of endothelial cells in other systems 
[41]. Importantly, the lack of IL-21 would seem to affect 
tumor-derived but not normal angiogenesis.
In conclusion, our studies reveal for the first time 
the crucial involvement of IL-21 in the mechanisms that 
control the growth of sporadic CRC.
Figure 8: Reduced angiogenesis in the tumors of IL-21 KO-Apcmin/+ mice. A. VEGF expression was assessed by ELISA 
in colon tissues taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. Data indicate mean ± SEM of two independent 
experiments in which at least four mice per group were considered. NT, non-tumor area, T, tumor area. B. Representative western blotting 
showing p-VEGF-R2 Tyr1175 and VEGF-R2 expression in colon tissues taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on 
day 56. β-actin was used as loading control. One of four representative experiments in which similar results were obtained is shown. C. 
Representative immunohistochemical staining of CD31 in colon sections taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on 
day 56. Staining with isotype control IgG is also shown. The scale bars are 20µm. One of four representative experiments is shown. Upper 
left inset. Quantification of blood vessels in colon sections taken from Apcmin/+ mice and IL-21 KO-Apcmin/+ mice killed on day 56. Data are 
presented as mean values of blood vessels per high power field (hpf) ± SEM of two independent experiments in which at least two sections 
per group were analyzed.
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MATERIALS AND METHODS
Patients and samples
Paired tissue samples were taken from the tumor 
area and the macroscopically unaffected, adjacent, colonic 
mucosa of 10 patients who underwent colon resection 
for sporadic CRC (all with TNM stage II-III) at the Tor 
Vergata University Hospital (Rome, Italy). These samples 
were used to extract total proteins as described elsewhere 
[42]. TILs were isolated from tumor samples as described 
below. No patients received radiotherapy or chemotherapy 
prior to undergoing surgery. The human studies were 
approved by the local ethics committee and each patient 
gave written informed consent.
Animals
Apcmin/+ mice, which spontaneously develop 
intestinal tumors, were obtained from Jackson (Bar 
Harbor, ME). IL-21 KO (129S5-Il21tm1Lex) mice were 
purchased from Lexicon Genetics Incorporated (The 
Woodlands, TX). IL-21 KO mice are viable and do not 
exhibit any phenotype. Both Apcmin/+ mice and IL-21 KO 
mice were established on a C57BL/6J background. Male 
Apcmin/+ mice were crossed with female IL-21 KO mice to 
obtain IL-21 KO-Apcmin/+ mice. Mice were routinely tested 
for health status and infections according to the FELASA 
guidelines. Mice were negative for all pathogens included 
in this protocol. Mice were also negative for Helicobacter 
hepaticus and Helicobacter bilis. All animal experiments 
were approved by the local Institutional Animal Care and 
Use Committee.
Isolation of tumor infiltrating leukocytes from 
human colonic samples
Tumor infiltrating leukocytes were 
isolated from CRC samples using dithiothreitol–
ethylenediaminetetraacetic acid and collagenase method 
as previously described [43].
 Cell cultures
All reagents were from Sigma-Aldrich (Milan, 
Italy) unless otherwise specified. The human-derived, 
nontransformed colonic epithelial cell line NCM460 
was purchased from INCELL Corporation (San Antonio, 
TX) and maintained in M3:10 medium (INCELL 
Corporation). The human CRC cell lines DLD-1 and 
HT-29 were obtained from the American Type Culture 
Collection (ATCC, Manassas, VA) and cultured in RPMI 
1640 and McCoy’s 5A medium respectively. All media 
were supplemented with 10% fetal bovine serum, 1% 
penicillin/streptomycin (both from Lonza, Verviers, 
Belgium) and 50µg/ml gentamycin. The murine CRC 
cell line MC38 was generously provided by Dr. Ignacio 
Melero (Universidad de Navarra, Pamplona, Spain) and 
maintained in DMEM medium supplemented with 10% 
fetal bovine serum and 1% penicillin/streptomycin.
Cells were maintained in a 37°C, 5% CO2, 
fully humidified incubator. Cell lines have been 
recently authenticated by STR DNA fingerprinting 
using the PowerPlex 18D System kit according to the 
manufacturer’s instructions (Promega, Milan, Italy). The 
STR profiles of all the cell lines matched the known DNA 
fingerprints.
To characterize IL-21 producing cells, freshly 
isolated TILs were cultured in the presence of phorbol 
12-myristate 13-acetate (PMA, 80 pM), ionomycin (1 mg/
mL), and monensin (2 µM, eBioscience, San Diego, CA) 
for 5 h, and then evaluated by flow cytometry following 
staining with specific fluorochrome-conjugated antibodies. 
An aliquot of cells was resuspended and cultured in 
complete RPMI 1640 medium and cell-free supernatants 
harvested after 48 h. To assess whether IL-21 activates 
STAT3 and/or NF-kB in human CRC cells, DLD-1 and 
HT-29 cells were either left untreated or cultured in the 
presence of either IL-21 (25-100 ng/ml, Life Technologies, 
Milan, Italy) or TIL-derived supernatants (used at 1:20 
final dilution) for 15 min.
To determine whether IL-21 activates STAT3 and/
or NF-kB in mouse CRC cells, MC38 cells were either 
left untreated or cultured in the presence of either IL-21 
(25-100 ng/ml, R&D Systems, Milan, Italy) or TIL SNs 
derived from Apcmin/+ mice (used at 1:20 final dilution) for 
15 min. To examine whether IL-21 affects human CRC 
cell proliferation and/or viability, DLD-1 and HT-29 cells 
were eiher left untreated or cultured in the presence of 
either IL-21 (25-100 ng/ml) or TIL-derived supernatants 
(used at 1:20 final dilution) or staurosporine for 12-72 h. 
To examine whether IL-21 affects MC38 cell proliferation, 
cells were eiher left untreated or cultured in the presence 
of either IL-21 (25-100 ng/ml) or TIL SNs derived from 
Apcmin/+ mice (used at 1:20 final dilution) for 24 hours.
To determine whether IL-21 controls pro-
tumorigenic signals in human TILs, cells were isolated 
from sporadic CRC of 4 patients, activated with anti-
CD3/CD28 in the presence of either a specific antibody 
neutralizing IL-21 (anti-IL-21, used at 10 µg/ml, Giuliani 
S.p.A., Milan, Italy) or control IgG (R&D Systems, Milan, 
Italy) and examined by flow cytometry after 24 h.
Assessment of cell proliferation and death
Cell proliferation was assessed by using a 
commercially available 5-bromodeoxyuridine (BrdU) 
assay kit (Roche Diagnostic). To assess cell death 
and apoptosis, cells were stained with fluorescein 
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isothiocyanate-conjugated annexin V (AV, Immunotools, 
Friesoythe, Germany) and 5μg/ml propidium iodide (PI) 
for 30 min at 4°C, and their fluorescence measured by flow 
cytometry. 
Western blotting
Total proteins were extracted from human CRC 
cells or human and mouse colonic tissues as described 
elsewhere [42] and separated by SDS/PAGE. Blots 
were incubated with antibodies to IL-21 (Millipore, 
Milan, Italy), p-STAT3 Tyr705, p-NF-κB/p65 Ser536, 
p-VEGF-R2 Tyr1175, VEGF-R2 (all from Cell Signaling, 
Danvers, MA), STAT3, p65 and IL-21R antibodies (all 
from Santa Cruz Biotechnology, Santa Cruz, CA). To 
ascertain equivalent loading of the lanes, blots were 
stripped and incubated with an anti-β-actin antibody.
Flow cytometry analysis
Flow cytometry analysis was performed by using 
a BD FACSVerse (BD Biosciences). Human TILs were 
stained with the following monoclonal antibodies: 
CD45-APC-H7, CD3ε-PerCP, CD8α-V500, CD56-PE-
Cy7, CD19-FITC, IFN-γ-FITC, IL-17A-V450 (all from 
BD Pharmingen, Milan, Italy), IL-21-PE, T-bet-PE-Cy7 
(clone 4B10), RORγt-APC (clone AFKJS-9), Foxp3-
FITC (clone PCH101), IL-22-APC, IL-6 PerCP (both 
from eBioscience), CD68-APC (Biolegend, San Diego, 
CA). Mouse LPMCs and TILs were stained with the 
following monoclonal antibodies: CD45-APC-Cy7, 
CD4-PerCP, CD8α-FITC, CD49b-PE (clone DX5), 
FoxP3-APC, IL-17A-PE, IFN-γ-PE-Cy7 (both from BD 
Pharmingen), perforin-APC, granzyme B-PE-Cy7 (all 
from eBioscience). In parallel, cells were stained with the 
respective control isotype antibodies.
Experimental model of sporadic CRC
Cohoused 6- to 7-week-old female Apcmin/+ and IL-
21 KO-Apcmin/+ mice received intraperitoneal injections of 
10 mg/kg azoxymethane (AOM) once a week for 2 weeks 
in order to increase colon tumorigenesis as previously 
reported [44]. Mice were killed 8 weeks after the first 
AOM injection (day 56). Colonoscopy was performed in a 
blinded manner for monitoring of tumorigenesis using the 
Coloview high-resolution mouse endoscopic system (Karl-
Storz; Tuttlingen, Germany). Tumors observed during 
endoscopy were counted to obtain the overall number of 
lesions. Tumor sizes of all tumors in a given mouse were 
scored using the protocol described by Becker et al [45].
Isolation of LPMCs and TILs from mouse colon 
tissues
LPMCs and TILs were isolated from colon non-
tumor and tumor areas of Apcmin/+ mice and IL-21 KO-
Apcmin/+ mice as previousy described [9].
Immunohistochemistry
Colonic cryosections of Apcmin/+ mice and IL-21 KO-
Apcmin/+ mice were stained with p-STAT3 Tyr705, p-NF-
κB/p65 Ser536 (both from Cell Signaling) and CD31 
(BD Pharmingen). Isotype control-stained sections were 
prepared under identical conditions replacing the primary 
antibody with either a rabbit or rat IgG control antibody 
(R&D Systems). Proliferating cells were evaluated using a 
PCNA staining kit (ZYMED Laboratories, Carlsbad, CA) 
according to the manufacturer’s instructions. Negative 
control-stained sections were prepared under identical 
immunohistochemical conditions omitting the primary 
antibody.
Analysis of cytokine and angiogenesis-related 
factors in mouse colonic tissues
One hundred µg protein was assessed by enzyme-
linked immunosorbent assay (ELISA) for IL-17A, IL-22, 
IL-6, tumor necrosis factor (TNF)-α, vascular epithelial 
growth factor A (VEGF-A; hereafter referred to as 
VEGF) (all from R&D Systems) and prostaglandin (PG)
E2 (Cayman Chemical, Ann Arbor, MI) according to the 
manufacturer’s protocols.
RNA extraction, cDNA preparation and real-time 
PCR
Total RNA was extracted from tumor and non-
tumor tissue of Apcmin/+ mice and IL-21 KO-Apcmin/+ mice 
using TRIzol reagent according to the manufacturer’s 
instructions (Life Technologies). Primers were as follows: 
IL-17A sense: 5’-TCAGACTACCTCAACCGTTC-3’ 
and anti-sense 5’-TTCAGGACCAGGATCTCTTG-3’, 
TNF-α sense 5’-ACCCTCACACTCAGATCATC-3’ and 
anti-sense: 5’-GAGTAGACAAGGTACAACCC-3’, IL-6 
sense: 5’-AGCCAGAGTCCTTCAGAGAG-3’ and anti-
sense 5’-GATGGTCTTGGTCCTTAGCC-3’, COX-2 
sense 5’-TTCTTTGCCCAGCACTTCAC-3’ and anti-
sense 5’-GGATACACCTCTCCACCAAT-3’. IL-22 RNA 
expression was evaluated using a TaqMan assay (Life 
Technologies). RNA expression was calculated relative to 
the housekeeping β-actin gene on the base of the ΔΔCt 
algorithm.
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Statistical analysis
Values are expressed as mean ± SEM and results 
analyzed using the two-tailed Student t test. Significance 
was defined as P-values < 0.05.
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